Efficacy and Safety of Intranasal Glucagon for Treatment of Induced Hypoglycemia in Adults with Diabetes
Phase of Trial: Phase III
Latest Information Update: 14 Oct 2016
At a glance
- Drugs Glucagon (Primary) ; Glucagon
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors AMG Medical
- 17 Dec 2015 Results published in the Diabetes Care
- 14 Apr 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 07 Jan 2015 Planned End Date changed from 1 Oct 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov record.